These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Commentary: do angiotensin II receptor antagonists regress left ventricular hypertrophy? Lip GY J Hum Hypertens; 1996 Nov; 10(11):725-7. PubMed ID: 9004101 [No Abstract] [Full Text] [Related]
24. Reversible acute renal failure induced by losartan in a renal transplant recipient. Ostermann M; Goldsmith DJ; Doyle T; Kingswood JC; Sharpstone P Postgrad Med J; 1997 Feb; 73(856):105-7. PubMed ID: 9122087 [TBL] [Abstract][Full Text] [Related]
25. A new class of antihypertensive: angiotensin II receptor antagonists. McCoy R S D J Med; 1995 Sep; 48(9):319-20. PubMed ID: 7481726 [No Abstract] [Full Text] [Related]
26. Losartan--a new antihypertensive. Drug Ther Bull; 1995 Oct; 33(10):73-4. PubMed ID: 7493558 [No Abstract] [Full Text] [Related]
27. ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema. Pylypchuk GB Ann Pharmacother; 1998 Oct; 32(10):1060-6. PubMed ID: 9793599 [TBL] [Abstract][Full Text] [Related]
28. Losartan in heart failure: preclinical experiences and initial clinical outcomes. Sweet CS; Rucinska EJ Eur Heart J; 1994 Dec; 15 Suppl D():139-44. PubMed ID: 7713103 [TBL] [Abstract][Full Text] [Related]
29. [Cross reactivity between ACE inhibitors and angiotensin receptor blockers]. Rosenborg S Lakartidningen; 2010 Feb 17-23; 107(7):444. PubMed ID: 20384078 [No Abstract] [Full Text] [Related]
30. Hereditary angioedema type III, angioedema associated with angiotensin II receptor antagonists, and female sex. Bork K; Dewald G Am J Med; 2004 May; 116(9):644-5. PubMed ID: 15093766 [No Abstract] [Full Text] [Related]
31. Losartan for hypertension. Med Lett Drugs Ther; 1995 Jun; 37(951):57-8. PubMed ID: 7783693 [No Abstract] [Full Text] [Related]
32. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching. Larochelle P; Haynes B; Maron N; Dugas S Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244 [TBL] [Abstract][Full Text] [Related]
33. A risk-benefit assessment of losartan potassium in the treatment of hypertension. Burrell LM Drug Saf; 1997 Jan; 16(1):56-65. PubMed ID: 9010643 [TBL] [Abstract][Full Text] [Related]
34. Angioedema of the intestine. Gabb GM N Engl J Med; 1996 Nov; 335(20):1534-5; author reply 1535. PubMed ID: 8927095 [No Abstract] [Full Text] [Related]
36. Olmesartan medoxomil-induced angioedema. Nykamp D; Winter EE Ann Pharmacother; 2007 Mar; 41(3):518-20. PubMed ID: 17341528 [TBL] [Abstract][Full Text] [Related]
37. Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension. Mallion JM; Goldberg AI Blood Press Suppl; 1996; 2():82-6. PubMed ID: 8913546 [TBL] [Abstract][Full Text] [Related]
38. Anaemia in dialysis patients as a side-effect of sartanes. Schwarzbeck A; Wittenmeier KW; Hällfritzsch U Lancet; 1998 Jul; 352(9124):286. PubMed ID: 9690412 [No Abstract] [Full Text] [Related]
39. [Losartan]. Pfaffendorf M Dtsch Med Wochenschr; 1996 Sep; 121(36):1101-2. PubMed ID: 8846756 [No Abstract] [Full Text] [Related]
40. [Angiotensin II receptor antagonists]. Bornkessel B Med Monatsschr Pharm; 1995 Jun; 18(6):148-51. PubMed ID: 7609710 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]